Clik here to view.
Recent news in the Italian Pfizer antitrust case
Daniela AmpolliniIn my earlier posts (here and here) I reported and commented on the first two phases of the Italian Pfizer antitrust case, in which the Italian Antitrust Authority (IAA) accused Pfizer...
View ArticleClik here to view.
Cloned Sheep And Other Patent Eligibility Issues In The U.S.
Courtenay C. BrinckerhoffLast week, in In Re Roslin Institute, the U.S. Court of Appeals for the Federal Circuit held that cloned cattle, sheep, pigs and goats are non-patent eligible subject matter...
View ArticleClik here to view.
Patentability of biotechnology inventions: "O time thou must untangle this,...
Miquel MontañáAlthough Brian Cordery will try to have you believe that the title of this blog is borrowed from William Shakespeare’s Twelfth Night, it may well have been taken from the Report from the...
View ArticleClik here to view.
Herceptin Round 2: Hospira enjoys the sweet smell of success once more
Brian Cordery and Steven WillisRegular readers of the Kluwer patent blog may recall that in April 2014, the English Patents Court revoked two patents relating to trastuzumab, the active ingredient in...
View ArticleClik here to view.
A Little German Christmas Present and some Year's End Reflections
Thorsten BauschThanks to Miquel Montaña’s brilliant Christmas post, we have learnt a lot about the lucina sine (aut cum) concubitu and the legal impact her involvement may have had for the application...
View ArticleClik here to view.
EPO: T 1729/06, Enhanced pollenizer and method for increasing seedless...
Jaap MannaertsInventions regarding a method of improving the yield of triploid seedless watermelons by pollination with a specific type of diploid water melon are not to be regarded as an essentially...
View ArticleClik here to view.
Monopoly on Test Results? Protection of Immaterial Products as “Fruits” of a...
Henrik Timmann Landmark European Patent CasesBased on method claims, German Patent Law does not only grant the patentee an exclusive right to exercise the method on the German territory, but also a...
View ArticleClik here to view.
Fordham Conference 2015 – Biosimilars
Daniel ByrnePenny Gilbert from Powell Gilbert LLP explains the position of biosimilars in the pharmaceutical industry. Biosimilars are essentially generic versions of biologics. Traditional generic...
View ArticleClik here to view.
U.S. Appeals Court Strikes Blow To Diagnostic Method Patents
Courtenay C. BrinckerhoffThe Federal Circuit has issued its long-awaited decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc., but the decision is not good news for those seeking to obtain or enforce...
View ArticleClik here to view.
SPC revoked, PI lifted, but no damages awarded
Daniela AmpolliniIn the Sanofi v. Teva ruling of 10 July 2014, the Court of Milan clarified the test for abuse of process, and denied an award of damages allegedly caused by the issue of a preliminary...
View ArticleClik here to view.
The best things in life are unexpected because there were no expectations...
Brian CorderyApart from the enthralling Lyrica saga which began in earnest back in January, and the main trial of which recently began before Arnold J, 2015 has not witnessed many significant...
View ArticleClik here to view.
U.S. Appeals Court Renders First Interpretations Of Biosimilars Law
Courtenay C. BrinckerhoffIn Amgen v. Sandoz, Fed. Cir., No. 15-1499 (July 21, 2015), a divided panel of the U.S. Court of Appeals for the Federal Circuit issued its first decision interpreting the...
View ArticleClik here to view.
Regeneron Pharmaceuticals Inc v (1) Kymab Ltd (2) Novo Nordisk A/S
Brian CorderyCase reported and summarized by Gregory Bacon, Bristows LLP Mr Justice Carr is only a few months into his judicial career, but having already provided welcome guidance on the role of...
View ArticleClik here to view.
Breaking News: Board of Appeal finds that Acetic Acid is no Inorganic Acid.
Thorsten BauschOkay, this result, which was recently reached by TBA 3.3.04 in decision T 394/11 (in German language), may perhaps not come as a big surprise to you, since we all learnt in school that...
View ArticleClik here to view.
AIPPI Milano – Similar but different
Vanessa RieuPanel session 2 of the second day of the Congress was a discussion session about biosimilars. Moderator Dominic Adair (Partner, Bristows (UK)) led his panellists Fritz Reiter (Regulatory...
View ArticleClik here to view.
Court of Appeal confirms revocation of trastuzumab/taxane combination patent
Brian Corderyby Chloe Dickson On 30 November 2016 the Court of Appeal handed down judgment in the latest chapter of the Hospira v Genentech epic surrounding Genentech’s blockbuster drug trastuzumab...
View ArticleClik here to view.
English Patents Court grants declaratory relief in relation to Humira® dosage...
Brian Cordery and Laura von HerzenOn 3 March 2017, the English Patents Court (Henry Carr J) issued a decision (here) in the joined claims filed by Fujifilm Kyowa Biologics (FKB) and Samsung...
View ArticleClik here to view.
Biologics & Biosimilars: Innovator vs Competitor
Dominic AdairThe afternoon of the first day of C5’s Pharma & Biotech conference in Amsterdam (27 February 2018) concluded with a lively panel session on biosimilars. Chaired by Bristows partner Dom...
View ArticleClik here to view.
China is to Establish Patent Linkage
Hui Zhang, Xiang Li, Dani Min and Jiao YuxinOn October 8, 2017, the Chinese Communist Party and the State Council jointly issued a special opinion on the reform of drug and medical device approval...
View ArticleClik here to view.
How do you solve a problem like… valid and infringed patents?
Adrian Chew and Rachel MumbyWhilst being wary of placing too much emphasis on statistics (the phrase “lies, damn lies and statistics” comes to mind), the authors have seen figures which suggest that...
View Article
